Stockreport

Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation [Yahoo! Finance]

Nasdaq, Inc.  (NDAQ) 
Last nasdaq, inc. earnings: 4/22 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.nasdaq.com
PDF Imlifidase is an enzyme that rapidly and efficiently cleaves all types of immunoglobulin G (IgG) antibodies both intra- and extra-vascularly to inhibit IgG-mediated imm [Read more]